Synthesis of 14,15-dehydroerythromycin A ketolides: Effects of the 13-substituent on erythromycin tautomerism

被引:3
作者
Fardis, M [1 ]
Ashley, GW [1 ]
Carney, JR [1 ]
Chu, DT [1 ]
机构
[1] Kosan Biosci Inc, Dept Chem, Hayward, CA 94545 USA
关键词
D O I
10.7164/antibiotics.54.278
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A ketolide was prepared from 14,15-dehydroerythromycin A by two different routes. The first approach involving oxidation of the 3-OH of 3-descladinosyl-14,15-dehydroerythromycin A 2'-O-acetate gave unexpectedly high levels of 3,11-double oxidation. This may be due to greater formation of the 9,12-hemiketal in 14,15-dehydroerythromycin A and concomitant exposure of the 11-OH group for oxidation. NMR studies of 14,15-dehydroerythromycin A support this hypothesis, revealing a 9 : 1 ratio of g-ketone to 9,12-hemiketal in CDCl3 and a 1 : 1 ratio in CD3OD as contrasted with the corresponding tautomer ratios of 30 : 1 in CDCl3, and 6. 1 in CD3OD with erythromycin A. Alteration of the 13-substituent on the erythronolide A ring from ethyl to vinyl thus favors formation of the 9,12-hemiketal. A second route to the ketolides was developed based on these findings, in which the 11-OH is eliminated prior to oxidation of the 3-OH.
引用
收藏
页码:278 / 284
页数:7
相关论文
共 10 条
[1]   Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives):: A new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens [J].
Agouridas, C ;
Denis, A ;
Auger, JM ;
Benedetti, Y ;
Bonnefoy, A ;
Bretin, F ;
Chantot, JF ;
Dussarat, A ;
Fromentin, C ;
D'Ambrières, SG ;
Lachaud, S ;
Laurin, P ;
Le Martret, O ;
Loyau, V ;
Tessot, N .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) :4080-4100
[2]   SYNTHESIS, INVITRO AND INVIVO ACTIVITY OF NOVEL 9-DEOXO-9A-AZA-9A-HOMOERYTHROMYCIN A DERIVATIVES - A NEW CLASS OF MACROLIDE ANTIBIOTICS, THE AZALIDES [J].
BRIGHT, GM ;
NAGEL, AA ;
BORDNER, J ;
DESAI, KA ;
DIBRINO, JN ;
NOWAKOWSKA, J ;
VINCENT, L ;
WATROUS, RM ;
SCIAVOLINO, FC ;
ENGLISH, AR ;
RETSEMA, JA ;
ANDERSON, MR ;
BRENNAN, LA ;
BOROVOY, RJ ;
CIMOCHOWSKI, CR ;
FAIELLA, JA ;
GIRARD, AE ;
GIRARD, D ;
HERBERT, C ;
MANOUSOS, M ;
MASON, R .
JOURNAL OF ANTIBIOTICS, 1988, 41 (08) :1029-1047
[3]   ANTIBACTERIAL ACTIVITY OF ROXITHROMYCIN - A LABORATORY EVALUATION [J].
CHANTOT, JF ;
BRYSKIER, A ;
GASC, JC .
JOURNAL OF ANTIBIOTICS, 1986, 39 (05) :660-668
[4]   KETONE HEMIACETAL TAUTOMERISM IN ERYTHROMYCIN-A IN NONAQUEOUS SOLUTIONS - AN NMR SPECTROSCOPIC STUDY [J].
EVERETT, JR ;
HUNT, E ;
TYLER, JW .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1991, (10) :1481-1487
[5]   Precursor-directed biosynthesis of erythromycin analogs by an engineered polyketide synthase [J].
Jacobsen, JR ;
Hutchinson, CR ;
Cane, DE ;
Khosla, C .
SCIENCE, 1997, 277 (5324) :367-369
[6]  
KROWICKI K, 1973, J ANTIBIOT, V26, P569
[7]   ACID DEGRADATION OF ERYTHROMYCIN-A AND ERYTHROMYCIN-B [J].
KURATH, P ;
JONES, PH ;
EGAN, RS ;
PERUN, TJ .
EXPERIENTIA, 1971, 27 (04) :362-&
[8]  
LEAF T, 2000, IN PRESS BIOTECHNOLO
[9]   CHEMICAL MODIFICATION OF ERYTHROMYCINS .1. SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF 6-O-METHYLERYTHROMYCINS-A [J].
MORIMOTO, S ;
TAKAHASHI, Y ;
WATANABE, Y ;
OMURA, S .
JOURNAL OF ANTIBIOTICS, 1984, 37 (02) :187-189
[10]   RESEARCH-AND-DEVELOPMENT OF CLARITHROMYCIN [J].
OMURA, S ;
MORIMOTO, S ;
NAGATE, T ;
ADACHI, T ;
KOHNO, Y .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1992, 112 (09) :593-614